Newsletter

Pol. Merkur. Lek (Pol. Med. J.), 2012, XXXII/191: 298-301 Maximize

Pol. Merkur. Lek (Pol. Med. J.), 2012, XXXII/191: 298-301

Title: Sarcoidosis and tobacco smoking – clinical picture, diagnostic tests results and bronchoalveolar lavage fluid composition

Authors: Urbankowski T., Knyziak-Mędrzycka I., Domagała-Kulawik J., Chazan R.

More details

04/191

40,00 zł

SUMMARY IN POLISH & ENGLISH. FULL ARTICLE ONLY IN POLISH.

Sarcoidosis and tobacco smoking – clinical picture, diagnostic tests results and bronchoalveolar lavage fluid composition


Urbankowski T.1, Knyziak-Mędrzycka I.1, Domagała-Kulawik J.2, Chazan R.2

Medical University of Warsaw, Poland: 1Students Scientific Club „Alveolus”, Department of Internal Diseases, Pneumonology and Allergology; 2Department of Internal Diseases, Pneumonology and Allergology

Sarcoidosis is a multiorgan granulomatous disease of unknown aetiology. Bronchoalveolar lavage (BAL) is approved in diagnostics of sarcoidosis.
The aim of the study
was to assess epidemiological data, demographic status, clinical picture of sarcoidosis patients and to correlate above-mentioned findings with smoking status.
Material and methods
. The study included 101 patients hospitalized due to suspicion of pulmonary sarcoidosis. The results of clinical assessment and smoking status data were obtained by retrospective analysis of 78 confirmed sarcoidosis case records.
Results
. Investigated group comprised 54 non-smokers (NS) and 24 smokers (S), including 9 (11.5%) active smokers (AS). Smokers were significantly younger than nonsmokers. Most of the smokers were males. The mean number of pack-years was 8.2. Respiratory symptoms occurred with similar frequency among non-smokers and smokers. The incidence of the Loefgren’s syndrome was similar in S and NS . The pulmonary function tests results were comparable in both groups, however, the obstruction was more frequent among smokers. Composition of BAL fluid (BALf) differed significantly between S and NS. The total cell count was significantly higher among active smokers than among nonsmokers (29.3±19.2 x 106 vs 13.7±6.3 x 106). Compared to non-smokers, smokers had higher number of macrophages and lower percentage of lymphocytes (11.3±11 x 106 vs 6.5±3.9 x 106, 29±19 vs 41±17%, respectively).
Conclusions
. A significantly lower proportion of smokers is observed among sarcoidosis patients than in general population. The influence of smoking on clinical picture and results of pulmonary function tests is not evident in sarcoidosis. However, tobacco smoking causes significant alteration in the composition of BALf , which should be taken into account in diagnostics of sarcoidosis.

Key words: sarcoidosis; smoking, diagnosis; bronchoalveolar lavage

Pol. Merk. Lek., 2012, XXXII, 191, 298